Unlocking Andrographis Paniculata's Anti-COVID-19 Potential: A Molecular Perspective

Written By Hiroshi Wald

  • Key Compounds Identified: The study identifies 24 potential active compounds in Andrographis Paniculata.

  • COVID-19 Specific Targets: Focuses on 11 critical targets, suggesting mechanisms for combating COVID-19.

  • Molecular Binding: Highlights compounds, especially andrographidine C, with strong affinity to ACE2 and PIK3CG proteins.

  • Therapeutic Implications: The findings suggest andrographidine C's direct influence on COVID-19 infection and replication processes.

This research provides a scientific basis for using Andrographis Paniculata in COVID-19 treatments, emphasizing its molecular interaction and potential therapeutic benefits.

Source: https://pubs.rsc.org/en/content/articlehtml/2021/ra/d1ra06487h

Hiroshi Wald
Previous

Andrographis Paniculata: A Potential Shield Against Pneumonia in Early COVID-19
Next

Andrographis has been mostly studied for colds, flu, and upper respiratory infections.